Surprisingly uneven distribution of the T cell receptor Vβ repertoire in wild mice by Potts, Wayne K. & Pullen, Ann M.
Published January 1, 1990
S U R P R ISIN G L Y  U N E V E N  D IS T R IB U T IO N  O F T H E  T  C ELL  
R E C E P T O R  V/3 R E P E R T O IR E  IN  W IL D  M IC E
By ANN M. PULLEN,*! WAYNE POTTS,5 EDWARD K. WAKELAND,$ 
JO H N  KAPPLER,*t1 and  PHILIPPA MARRACK*tlH
From the * Howard Hughes Medical Institute at Denver, tDivision of Basic Immunology, 
Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, 
Colorado 80206; the *Department o f Pathology, College of Medicine, University of Florida, 
Gainesville, Florida 32610; and the IDepartments of Biochemistry, Biophysics, and Genetics, and the 
^Departments of Microbiology, Immunology, and Medicine, University of Colorado Health Sciences
Center, Denver, Colorado 80206
Heterodimeric TCR-a/j8s are made up of combinations of V, D, J, and C ele­
ments. The majority of laboratory inbred mouse strains are of the V/3b haplotype 
and have at least 20 V/3 genes from which to construct TCRs (1, 2); however, a number 
of strains have been reported to have deletions of large portions of the V/3 locus on 
chromosome 6 (3-5), and these mice must survive with a considerably reduced poten­
tial TCR repertoire.
Generally, all the variable elements of the TCR (Vo/, Ja , V/3, D/3, and J/3) con­
tribute to binding of a conventional antigen-MHC complex. A second group of an­
tigens that stimulate T cells via their TCR V/3 element alone, essentially with no 
regard for the other components of the receptor, has recently been documented and 
termed superantigens (6, 7).
The self superantigens, which include the much studied but little understood mixed 
lymphocyte stimulating locus (Mis)1 determinants, have been shown to play an im­
portant role in shaping the T  cell repertoire. T  cells reactive with such self superan­
tigens are eliminated in the thymus by clonal deletion (8), the mechanism of which 
is as yet unknown. CBA/J and CBA/CaJ are closely related mice, for example, and 
yet they differ by ~30% of their T  cell repertoire because the expression of M ls-la 
and Mls-2a or -3a in CBA/J animals leads to the elimination of virtually all T cells 
bearing V/3-6, -8.1, and -3 (9-12).
There has been some discussion as to whether the survival of mice with the V/3 
gene deletion or elimination of such a huge portion of their T  cell repertoire is an 
artifact of the laboratory inbred mice. The laboratory strains presumably have to 
cope with a limited number of pathogens since they are maintained in relatively 
clean conditions. We set out to analyze the TCR usage of wild mice to determine
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whether mice surviving under strong selective conditions also express and survive 
with depleted repertoires.
Our results showed a surprisingly uneven distribution of the TCR repertoire in 
the wild mice, with many of the mice homozygous for an extensive gene deletion 
and many examples of lowered expression of severed V/3s, probably due to tolerance 
to self superantigens. Interestingly, V|88.2 expression was suppressed in Mls-la mice. 
Since laboratory mouse strains have few V/38.2+ T cells with M ls-la reactivity (9), 
this finding facilitated the elucidation of the amino acids that contribute to Mis binding.
Materials and Methods
Mice. W ild mice were trapped at three independent sites around Gainesville, FL. All 
other mice were purchased from The Jackson Laboratory, Bar Harbor, ME.
Cell Lines. T  cell hybridomas were prepared by fusion of an a/3~ derivative of the A K R 
thym om a BW5147 (13) to Con A-stim ulated spleen cells expanded for 2 d in IL-2 (14). T  
cell hybridomas DO-11.10/S4.4 (15) and 3DT-52.5 (16) were used as controls.
Stimulation Assays. H ybridom as were screened for reactivity to M ls-la by stim ulating 105 
of these cells with 106 spleen cells from either CBA/J (M ls-la) or B10.BR (M ls-lb). Lym- 
phokine production was assayed after 24 h using the HT-2 cell line as an indicator (14).
Analyses of V/3 Expression. Lymph node T  cells were prepared on nylon wool columns, while 
thymocytes were prepared and cultured for 3 h as previously described (6). These cells were 
stained with biotinylated anti-V/3 or anti-a/3 antibodies followed by phycoerythrin streptavidin 
(PEAv; Tago Inc., Burlingame, CA) as outlined previously (6).
T he panel of anti-V /3 antibodies used included anti-V/32, B20 (M alissen et al., unpublished 
observations), anti-V/33, KJ25 (11), anti-V/35, M R 9-4 (Kanagawa et al., unpublished obser­
vations), anti-V/36, RR4-7 (17), anti-V/37, TR130 (Okada et al., unpublished observations), 
anti-V/38.1 + 8.2+8.3, F23.1 (18), anti-V/38.1 + 8.2, KJ16 (19), anti-V/38.2, F23.2 (18), anti-V/311, 
RR3 (20), and anti-V/317 a, KJ23a (21). All V/3 levels are expressed as a percentage of cells 
bearing the TCR-a//3, as determ ined by staining with H57-597 (22).
Unseparated lymph node cells were stained with biotinylated anti-IE, 14.4.4 (23), and PEAv. 
All stained cells were analyzed by using an Epics C flow cytometer as previously described (24).
Analyses of Vt38 Gene Usage. V/38 gene usage by hybridomas was determ ined using V/38.1 
leader (C T C T T C T T T G TG G T T T TG A T T )- and V/38.2 exon (CAGACTAATAACCACAA- 
CAAC)-specific oligonucleotides. Total RNA was prepared from 107 hybrid cells. 1 fig RNA 
was used for the synthesis of cDNA using an antisense oligonucleotide specific for C/3 
(GG C TA C CCTC GTG TG CTTGG C ) and reverse transcriptase (Amersham Corp., Arlington 
Heights, IL). The reaction was then heated for 5 m in at 95°C before amplification of the 
cDNA using the discrim inatory oligonucleotides specific for V/38.1 or V/38.2 shown above, 
the C/3 oligo, and 0.5 U  of Taq polymerase (Perkin-Elmer Corp., Norwalk, CT). The fol­
lowing amplification conditions were provided by a thermocycler (Cetus Corp., Emeryville, 
CA); 95°C melting, 55°C annealing, and 72°C extension, each for 2 min.
Sequencing of V(38 genes. Total genomic DNA was prepared from liver. V/38 genes were 
equally amplified using the polymerase chain reaction and 1 fiM external oligonucleotides 
(V/38.1, sense, C T C T T C T T T G T G G T T T T G A T T  and antisense, G  A A ATAGGG A A A AC - 
TAGCTCT; V/38.2, sense, C T C T T C T T C G T G C T C T C C A G T  and antisense, GAAATAAG- 
GAGAACAAAGTGC) under the conditions described above. Subsequently, the gel-purified 
dsDNA was subjected to unequal amplification using 1 /tM  of external (see above) and 0.01 
HM  of internal oligonucleotides (V/38.1, sense, C A C T G G T G T G C T T T C T T  and antisense, 
T G G C T TC C TTC A C TC TG C A C A ; V/38.2, sense, C A G G T G T G C T T C T C TC T C C A  and 
antisense, G G G T T T C C TC C C C T C T G C A C A ) to generate single-stranded cDNA, again 
using the same conditions. T he amplified positive or negative strand DNA was sequenced 
by the chain term ination method (25) using the Sequenase kit from U nited States Biochem­
ical Corp., Cleveland, O H .
Southern Analysis. Liver DNA was digested, subjected to electrophoresis, and transferred 
to nitrocellulose, as described by M aniatis et al. (26). Filters were hybridized with V/3 probes
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V/31 (Palmer and Yague, unpublished observations), V/36 (27), V/88, -10, and -15 (28), V/817
(21), and C/3 (29), and were labeled by random  prim ing (30). The two fined stringency washes 
were in 0.1% SSC, 0.1% SDS at 55°C for 30 min.
Results
41 wild mice (Mus musculus domesticus) were trapped at three independent sites around 
Gainesville, FL. Lymph node cells from these animals were stained with a mAb 
that reacts with all mouse IE molecules. All but one mouse expressed IE (data not 
shown). Purified lymph node T cells and thymocytes were stained with a collection 
of the available anti-V|3 antibodies and an antibody to all mouse a//3 receptors (22). 
There are, at present, antibodies to only about half the murine V/3s and the percen­
tages of peripheral and thymus a//3+ T cells bearing any of the detectable V|8s were 
determined.
Two mice had extraordinarily uneven V/3 expression. One contained 97% V/311 + , 
and the other, 40% V/38.2+ T  cells. This was probably a consequence of tumors, 
or recent exposure to an environmental superantigen (6 and Callahan et al., unpub­
lished observations). These two animals -were excluded from further analysis.
Fig. 1 shows a summary of the staining data for V|8 expression on peripheral T  
cells in the remaining 39 mice. To facilitate further discussion, the mice have been 
divided into four groups. The staining data for an individual mouse from each of 
these groups are shown in Table I.
Deletion of V/3 genes. T cells bearing a particular V/3 may be absent from the pe­
riphery either because of V/3 gene deletion or inactivation, or because of self super-
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Figure 1. Peripheral V/3 expression by wild mice. Purified lymph node T cells from 39 wild 
mice were stained with a panel of anti-V/3 antibodies. V/3 levels are expressed as a percentage 
of a/|3+ cells as determined using H57-597 (22). Cl, ER, and HS were three independent sites 
around Gainesville, FL, where the wild mice were trapped. (A) Mice homozygous for a deletion 
of V0 genes. (B) Mls-lb mice with F23.2+, V/38.2+ cells. (C) Mls-lb mice with F23.2', V/38.2* 
cells. (D) Mls-la mice with F23.2- , V/38.2+ cells. C57BL/6 mice were used as controls, and in 
six experiments, the mean ± SEM for the percentages of T cells expressing each V/3 in this 
strain were as follows: V/32, 6.0 ± 0.2; V/33, 3.8 ± 0.1; V05, 6.7 ± 0.3; V/36, 7.9 ± 0.2; V/37, 
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T a b l e  I
Ind iv id u a l M ice Express Different V/3 Repertoires
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CI26 A 23.0 0.7 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0
CI22 B 15.1 0.1 0.1 5.8 5.2 21.0 14.9 9.2 8.1 0.0
HS07 C 7.1 0.2 3.1 12.5 4.7 34.6 24.5 0.0 2.3 0.0
ER21 D 16.4 0.1 0.9 0.4 9.2 8.2 1.6 0.0 5.3 0.0
Purified peripheral T  cells were stained with the panel o f available anti-V/3 antibodies (see M aterials and 
M ethods), and results are expressed as percent of all a//3 + T  cells, as determ ined by staining with H57-597
(22).
* G roups are  those assigned in Fig. 1.
J V/38.2 specificity was determ ined for laboratory mice (9).
antigen-mediated elimination in the thymus (6). These two mechanisms can be dis­
tinguished by examination of V/3 expression on thymocytes. Self superantigens 
eliminate almost all mature T  cells and mature thymocytes expressing a particular 
Vj8, but only about half of immature thymocytes. Therefore, the presence or ab­
sence of particular V/3 on immature thymocytes can be used to distinguish between 
clonal elimination and gene deletion as mechanisms for inhibition of expression of 
a particular V/8 (Fig. 2).
10 of the mice, shown in group A (Fig. 1 A and Table I), had no V/35, -6, -8,
F ig u r e  2 . V/36 expression by thymocytes from wild 
mice. Thymocytes were cultured for 3 h before staining 
with anti-TCR reagents. Percentages refer to the frac­
tion of a//3+ T cells. KJ23a was used here as a  negative 
control (dotted line).
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or -11-bearing T cells in their peripheral lymph nodes and, moreover, had no thymo­
cytes expressing these V/3s (Fig. 2 C). Southern blot analysis of liver DNA from these 
mice confirmed that the genes for some of these V/3 elements were absent (Fig. 3). 
These mice had deleted all the members of the V/35 and V/38 gene families and V/36, 
-9, -11, -12, -13, and -15, which is at least half of the mouse V/3 genes. Comparison 
of these data with a V/3 gene map (31) indicated that the deletion began upstream 
of V/85 and extended over at least 100 kb to a point downstream of V/315.
The V/3 deletion in these Floridian mice was not the same as those previously 
reported for laboratory mice. Strains of the V/3a haplotype, SJL, SWR, C57L, 
C57BR (3), and AU SS/J (4), carry a deletion extending from upstream of V/85 
to downstream of V/89. Unlike the Floridian mice, these laboratory mice contain 
and express V/36 and V/315. Recently, another V/3 gene deletion has been reported 
in the inbred strain, RIII S/J (5). This deletion includes V/317 and so extends one 
V/3 gene further downstream than the deletion carried by the wild mice of this study.
Chromosomes carrying the V/3 gene deletion were only detected in the C l and 
ER populations. Southern blots of DNA from mice in these populations were used 
to find out which of the mice that contained T cells expressing V/3s included in the 
deletion were in fact heterozygous for the deleted chromosome. Heterozygotes were 
distinguished from mice homozygous for the nondeleted V/3 locus by comparing
PULLEN ET AL. 53
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F ig u r e  3. V/3 gene deletion extends from downstream of V/31 to downstream of V/315: Liver 
DNA from BALB/c, SJL, and wild mice ER36 and CI09 (Fig. 1, group A) was digested to com­
pletion with Eco Rl and Hind III. V/31, V/38, and V/315 probes were used on Southern blots 
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the intensities of V/88.1 and V/38.2 bands with the intensity of the nonpolymorphic 
V/31 band (data not shown). The results of this analysis showed that the gene fre­
quency of the V/3 deletion was 0.56 and 0.36 in the C l and ER populations, respec­
tively. The fact that both populations contained individuals homozygous for the deleted 
chromosome (41% in C l and 9% in ER) indicated that this reduction in the V/3 
repertoire was a competitive phenotype at both trapping sites.
None of the mice analyzed expressed V/3l7a, as determined by thymic staining 
with KJ23a (21). However, the wild mice had a gene hybridizing with a V/317 probe 
that showed the same V/317 restriction fragment-length polymorphism as BALB/c 
(Fig. 3). This pattern has recently been shown to be indicative of a pseudogene gener­
ated by a premature stop codon (32). Therefore, the wild mice probably contained 
the nonfunctional V/3l7b allele of this gene.
Further analysis of V/3 and C/3 polymorphisms (data not shown) demonstrated 
that there are at least three chromosomes segregating in these wild populations that 
have not been previously documented for laboratory inbred strains. These will be 
the subject of future investigations.
Self Superantigens Shape the T  Cell Repertoire. It has recently been demonstrated that 
laboratory mice expressing the M ls-la allele eliminate thymocytes bearing V/36, 
V/38.1, and V/39 (9, 10, 33), while those expressing Mls-2a and/or Mls-3a eliminate 
their V/33+ T  cells (11, 12). Fig. 1 (B -D ) shows that elimination patterns reminis­
cent of those seen for M ls-la-bearing inbred strains also occur in wild mouse popu­
lations. Mice containing high levels of V/36- and V|88.1-bearing T  cells, animals which 
were presumably Mls-lb, are shown in Fig. 1, B and C. Presumed Mls-la-expressing 
mice, which expressed low levels of peripheral T  cells bearing V/3-6, -8.1, and -8.2, 
are shown in Fig. 1 D. The deletion of V/88.2 cells will be discussed below.
O f the 39 mice, expression of M ls-la could be examined in only 29, since dele­
tion of the genes for V/36 and the V/38 precluded a test in 10 of the mice (Fig. 1 
A). Nevertheless, M ls-la appeared to be expressed with the reasonable frequency 
of 8 of 29 in the mice we could examine. There was some indication that expression 
of M ls-la was population specific, because the gene was expressed only in animals 
from the ER site (Table II). Whether this is a significant finding, or an artifact of 
the relatively small numbers of animals we have tested, awaits further investigation.
Clonal elimination of T cells bearing V/33 was found in all four of the groups of 
mice shown in Fig. 1. It was striking that as many as 32 of the 39 mice we examined 
expressed V/33 with low frequency on peripheral T cells (<2%), presumably due 
to tolerance induced by Mls-2a or Mls-3a (11, 12) (Table II).
Other examples of clonal elimination of T  cells reactive to self superantigens have 
been reported. V/35, -11, and -12 bearing T  cells, like those bearing V/3l7a, are elimi­
nated in mice expressing IE (8, 20, 34, 35). We found examples of these phenomena 
in the wild mice. Thus, of those mice in which it could be analyzed, 21 of 29 had 
low levels of V/35+ T  cells (<2%) and only two mice had V/35 levels >5% (Table 
II). However, despite the fact that all but one of the wild mice expressed IE, the 
majority of the mice in which it could be analyzed expressed high levels of V/Sll+ 
T cells (Table II). Moreover, there was no correlation with IE expression for the 
few mice that did have low V/311 levels. Therefore, V/311 expression in the wild mice 
did not seem to be controlled by the same elements as in laboratory animals. Per-
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T a b l e  II
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Gene Deletion, Gene Mutation, and Self Superantigens Eliminate 
V0s from the Repertoire





V/S Cl ER HS Total*
5, 6, 8, 9, 11, 12, 13, 15 Gene deletion 9/21 1/12 0/6 10/39
17 Gene mutation 21/21 12/12 6/6 39/39
6 and 8.1 Mls-la 0/12 8/11 0/6 8/29
3 Mls-2a/3a 16/21 11/12 5/6 32/39
5 IE + “X” 10/12 8/11 3/6 21/29
11 IE + “Y” 2/12 0/11 0/6 2/29
* V/3-5, -6, -8, and -11 are included in the gene deletion, and so the effects of 
the self superantigens on these V/3s could only be assessed in the mice that 
had the full complement of genes.
haps this reflects the presence in the wild mouse population of variant V/311-, variant 
IE-, or associated variant superantigens.
Mls-reactive V08.2+ T  Cells. An altered V08.2 gene product was detected in mice 
from the ER and HS populations, shown in Fig. 1, C and D. This V/38.2 element 
did not bind the F23.2 antibody, which is specific for V/38.2 elements of laboratory 
mouse strains (9), although it did bind the KJ16 antibody, specific for V|88.1 and 
-8.2 of laboratory mice (Table I). Southern blot analysis of Eco R l digests of liver 
DNA from mice with this altered staining pattern showed a V/38.1 band at the same 
position (4.4 kb) as in laboratory mice, but a smaller V/38.2 band (0.27 kb), as shown 
in Fig. 4.
As mentioned above, the presumed M ls-la mice (Fig. 1 D) eliminated F23.2- , 
V/38.2+ T  cells, in addition to those bearing V06 and -8.1. This result was unex­
pected because in laboratory inbred strains the majority of Vj88.1+ T  cells are Mls- 
l a reactive and are eliminated in mice bearing this self superantigen, while few 
V/38.2+ T  cells show M ls-la reactivity (9).
To confirm the Mis reactivity of these F23.2- , V/38.2+ cells, hybridomas were 
generated from spleen cells of a mouse that expressed the variant V|88.2+ but lacked 
M ls-la, ER33 (group C). All but one of the Vj38.1+ or V/38.2+ KJ16-binding T  cell 
hybrids from this fusion reacted to M ls-la stimulation (Table III). V|3 usage by the 
hybrids was analyzed by using V/38.1- and -8.2-specific oligonucleotides and the po­
lymerase chain reaction.
Table III shows that all the F23.2~, V/38.2+ hybrids generated from ER33 (group 
C) responded to M ls-la. Only 50% of the hybrids were reactive from a fusion of 
spleen cells from CI02 (group B), which bore a F23.2+, V/38.2 product. M ls-la was 
not expressed in the mice from site C l (Table II), and so the reactivity of this V/38.2 
could not be assessed by analyzing the peripheral levels of V08.2+ cells in these 
mice. We have previously shown that only 13% of V/38.2+ hybrids from B10.BR 
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2 .3 — Ficure 4. Some wild mice have an altered V/38.2 gene. A Southern
2 .0  — blot of Eco RI digests of liver DNA from a panel of wild mice was probed
with a V|88 probe. The staining patterns for the mice are shown in Fig. 
1. CI09, group A; HS18 and CI18, group B; HS26 and ER37, group 
C; and ER35, group D.
0 .6 -
It shou ld  be n o te d  th a t th e  M ls - la s tim u la tio n  o f  th e  V/38.1- a n d  V /38 .2-bearing  
h y b rid s  (Table I II )  a n d  o f  V /36-bearing  h y b rid s  (d a ta  n o t show n) g en e ra te d  from  
the  wild m ice stren g th en s o u r  ea rlie r assum ption  th a t the dele tion  o f  Vj36+, V/38.1+, 
a n d  V /38.2+ T  cells in  these  w ild m ice was d u e  to  to le ran ce  to  th e  M ls - la an tig en .
Table I I I
V/38.1 + and V /38.2+ T  Cell H ybrids fro m  W ild  M ice  
Are M ls - la Reactive
Source of No. of Percent
T cell mAb binding No. of Mis-1 “-reactive Mls-la-reactive
hybrids K.J16 F23.2 V0 hybrids hybrids hybrids
CI02 + - 8 .1 * 8 8 100
+ + 8 .2* 8 4 50
ER33 + - 8 .U 10 9 90
+ - 8.2* 13 13 100
T cell hybridomas were generated from spleen cells from CI02 (group B) and 
ER33 (group G). Con A-stimulated spleen cells were expanded in IL-2 be­
fore fusion to BW/a//3 “ . KJ16 + hybrids were selected, and tested for Mls-la 
reactivity by stimulation with CBA/J spleen cells and with B10.BR spleen cells 
as a haplotype-matched Mls-lb control.
* V/3 assignments were made by staining with F23.2 (anti-V/38.2).
t V/3 assignments were made by preparing total RNA, generating cDNA us­
ing a C/S-specific oligonucleotide and reverse transcriptase, and by using V/38.1-, 
V/38.2-, and C/3-specific oligonucleotides and the polymerase chain reaction 
to amplify the V/38 genes. Amplified DNA was run out on a 0.7% agarose 
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The PCR-amplified V/38.1 and -8.2 genes from some of the wild mice were se­
quenced and are shown in Fig. 5. The altered V/38.2 gene of cells that did not bind 
F23.2 and that were M ls-la reactive contained five amino acid substitutions, which 
distinguished it from conventional Vj88.2. One of these changes, asparagine to aspartic 
acid at position 22, was shared by the wild mouse F23.2+, V/38.2+ cells (group B), 
50% of which were M ls-la reactive. Therefore, this amino acid may contribute to 
Mis reactivity by some of these cells. Two other amino acid substitutions (asparagine 
to serine at 8 and glycine to aspartic acid at 51) are changes that convert V/38.2 residues 
into those found in the same position in V/38.1, the Mls-1 “-reactive member of the 
V/38 family in laboratory inbred mice. Therefore, these may also contribute to in­
creased Mis reactivity. The remaining amino acid substitutions at positions 70 and 
71 are unique to this wild V/38.2 gene. It is the two base changes at position 71 that 
generate the new Eco R l site in this altered V/38.2 gene (Fig. 4).
Discussion
It is not possible to estimate the size of the mouse a//3 T  cell repertoire accurately. 
The repertoire is probably on the order of 1010 different receptors, but is reduced
aa nos. 10 20 30
CS7BL/6 V08.2 GCAGTCACCCAAAGCCCAAGAAACAAGGTGGCAGTAACAGGAGGAAAGGTGACATTGAGCTGTAATCAGACTAATAACCACAACAACATGTAC 
A V T Q S P R N K V A V T G G K V T L S C N O T N N H N N M Y
CI27 V/98.2 .............................................................................................................. G..................................................
ER34 V08.2 ......................................G......................................................................G..................................................
C57BL/6 V08.1 .............................................................................................................. ..............................TG»*T*T..........
................................ ..... .................................................................... ..... ..........................D Y • •
40 50 60
C57BL/6 V/38.2 TGGTATCGGCAGGACACGGGGCATGGGCTGAGGCTGATCCATTATTCATATGGTGCTGGCAGCACTGAGAAAGGAGATATCCCTGATGGATAC 
W Y R Q D T G H G L R L I H Y S Y G A G S T E K G D I P D G Y
CI27 V08.2 ...................................................................................................................................................................
ER34 V0S.2 ...................................... A......................... C...................A........ G..................................G***
C57B/6 V08.1 ............................................................................. ..............TO**'A..........G........................................G*”
70 80 90
C57BL/6 V18.2 AAGGCCTCCAGACCAAGCCAAGAGAACTTCTCCCTCATTCTGGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCTGTGCCAGCGGTGAT 
K A S R P S Q E N  F S L  I L E L A T P S Q T S V . Y F C A S G D
CI27 V08.2 ............................................. -
6R34 V08.2 ....................................A-G»J
................................ .....  E
C57BL/6 V08.1 ............................................. '
...........................................................................................  L • • • A ...........................S
Figure 5. Sequences of V/38.2 genes from wild mice. The sequences shown for the V/38.1 and 
V/38.2 genes of C57BL/6 have been previously published (44). Oligonucleotides used for the 
amplification and sequencing of the wild mouse genes are shown in Materials and Methods. 
Sequence CI27 was identical to that obtained for CI19 (group B). Sequence ER34 was identical 
to that for ER14 and ER35 (group D), and differed at only one base (phenylalanine at position 
72), from HS26 (group C).
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in individual animals by the phenomena of positive selection and tolerance (36-38). 
A first thought might suggest that evolution would select animals with the largest 
T cell repertoires. Such animals would presumably be able to recognize and deal 
with more environmental pathogens.
It was therefore surprising to discover that all mice did not act to maximize the 
total number of useful TCRs they could express. Some laboratory mouse strains 
lack the genes for about half the mouse V/3s (3-5), an observation that was also found 
for some wild mice trapped in the Orkneys, Scotland (39). Another mouse strain 
lacks half the possible J/3s (40). Other laboratory mice limit their total T  cell reper­
toire in an unexpected way by self tolerance. O f course, tolerance to self is an all 
important prerequisite of a useful immune system, and immunologists have always 
assumed that the repertoire of lymphocytes would be somewhat limited because cells 
specific for self would be eliminated or suppressed. It was a surprise, however, to 
find out how dramatic the effects of tolerance could be, and that the products of 
single genes, called self superantigens, could lead to the elimination of substantial 
portions of the T  cell repertoire.
It is possible that repertoire restriction of this type is permitted in laboratory mice, 
which lead a relatively pathogen-free life, but might not be frequently observed in 
wild animals under constant challenge from environmental pathogens. To test this 
idea we screened a collection of wild mice, trapped in three independent locations 
in Florida, both for genetic deletion of V/3s, and for self superantigen-mediated clonal 
elimination of T cells bearing particular V/3s.
The Floridian animals were frequently homozygous for a large deletion in the 
V/3 locus, encompassing 12 of the known V/3s. The deletion-carrying chromosome 
found in these mice was not the same as that in SJL or RIII or other laboratory 
strains, because it included two V/3s not deleted in SJL mice, and differed from the 
RIII chromosome 6 by the presence of a V/317 gene, albeit, as the nonfunctional 
V/317b allele. The existence of these three independent extensive gene deletions within 
the V/3 locus suggests that this deletion is not deleterious.
Additionally, the wild mice expressed V/3-eliminating self superantigens with high 
frequency (Table II). Virtually no animal expressed high levels of V/35+ T cells, even 
though more than two-thirds of the mice contained functional V/35 genes. V/33-bearing 
T cells were also eliminated at high frequency by self superantigens. Less frequently, 
V/36+ and V/38.1+ cells were eliminated by, presumably, expression of M ls-la. The 
wild mice had, in fact, found a way to eliminate an additional V/3, V/38.2, the expres­
sion of which is not affected by self superantigens in laboratory strains. The selec­
tion of this additional V/3 with reactivity to the self superantigen, Mls-la, strengthens 
the argument that it is advantageous to maintain variation in the T cell repertoire 
using polymorphic self superantigens.
On the other hand, some V/3s were unexpectedly expressed in the wild mice, par­
ticularly V/311. Laboratory animals expressing IE eliminate Vj3ll-bearing cells (20, 
34, 35). This did not occur in the wild mice we tested, even though almost all of 
them expressed IE. Perhaps this result is indicative of an altered VjSll gene in the 
wild population, a possibility that will be examined in the future.
Overall, these data show that the mouse populations examined contained T  cells 
able to express nearly all mouse V/3s, but that each individual mouse was able to 
use only a subset of all these V/3s as part of its TCRs. This suggests that expression
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of all V/3s is not evolutionarily preferred for individual mice, an unusual evolutionary 
gambit, which is reminiscent of MHC gene expression. For MHC genes also, in­
dividual mice or men are limited in the total number of genes they can express, 
two at each allele, although the population at large has considerable diversity.
What evolutionary mechanisms may be responsible for the maintenance of vari­
ability in V/3 expression? We suggest that two opposing selective pressures are respon­
sible for this phenomenon. The deleterious effects of bacterial toxins, such as the 
staphylococcal toxins, may select for individuals with reduced V/3 repertoires. The 
staphylococcal toxins are powerful V/3-specific T  cell-stimulating superantigens in 
mouse and man (6, 7, 41). Unpublished experiments have shown that laboratory 
mice containing normal numbers of T  cells, but lacking those with which a partic­
ular toxin can interact, are resistant to the pathogenic effects of that toxin. A similar 
phenomenon may allow toxin resistance in wild mice, thus favoring individuals with 
repertoires lacking particular V/3s.
The toxin-mediated selection for fewer V/3s may be counterbalanced by selection 
for immune responsiveness against other endemic pathogens infecting natural mouse 
populations. Parasitic antigenicity is capable of rapid evolution (42), and the notion 
that parasites are selected for expression of antigenicity that occupies blind spots 
in the immune responsiveness of their hosts has been postulated many times (reviewed 
in references 43 and 44). Consequently, individuals with larger V/3 repertoires, and 
therefore fewer blind spots, would be predicted to be favored during interactions 
with pathogens other than those producing superantigens.
Control of V/3 expression at numerous independently segregating genetic loci, 
V/3, M HC, and the self superantigens, has the additional advantage of shuffling the 
V/3 repertoire in individual mice, such that numerous V/3 phenotypes are generated 
within a given mouse population. This shuffling in V/3 usage patterns randomizes 
the patterns of immune response blind spots expressed among individuals. Thus, 
pathogens with antigenicity that exploits one blind spot would not be at an advan­
tage when infecting individuals within the same deme with different blind spots, 
a phenomenon that will blunt the effectiveness of this mode of pathogen evolution.
Several other points emerge from the data presented in this paper. First, there 
was some evidence that V/3 expression was under different pressures at the different 
sites where mice were trapped. As noted above, for example, M ls-la expression, and 
concomitant elimination of V/36, -8.1, and -8.2+ T  cells, was only found in animals 
from one site (Table II). Likewise, mice homozygous for the V/3 gene deletion were 
found primarily at one site.
Second, the alterations in V/38.2 that convert these receptors to M ls-la reactivity 
may give some indication of the sites on V/3 with which self superantigens react. 
The TCR model proposed by Chothia et al. (45) predicts that four of the amino 
acid substitutions in the altered V/38.2 would occur in framework regions of the 
receptor. However, aspartic acid at position 22 would be an exposed charged res­
idue, close to the predicted antigen/MHC-binding site, and so may contribute to 
the 50% Mis reactivity of the V/38.2 receptors of the wild mice in group B, which 
have this single amino acid substitution. The aspartic acid for glycine substitution 
at position 51 falls in a predicted complementarity determining region forming part 
of the antigen/MHC-binding site of the TCR. Moreover, there is an aspartic acid 
at this site in the Mls-1 “-reactive, V/38.1 sequence (46), so this residue may well con­
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tribute to the strong M ls-la reactivity of the variant V/38.2. It should be noted, how­
ever, that this position is not an aspartic acid in another M ls-la-reactive V/3, V/36.
Summary
We have examined TCR V/3 expression in a collection of wild mice. Many of the 
mice were homozygous for a large deletion at the V/3 locus, and many animals also 
suppressed expression of several V/3s using self superantigens. Expression of V/38.2 
was unexpectedly suppressed by a self superantigen in some wild mice, which was 
due to the presence in these animals of a variant V/88.2 gene. The amino acid changes 
in this gene product suggest contact sites between V/3 and the superantigen.
Although all V/3s are expressed within each wild mouse population, individual 
mice have a limited and variable V/3 repertoire. The independent origin of multiple 
V/3 deletions and the presence of polymorphic self superantigens suggest that this 
variation may be maintained by balancing selection.
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